Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrimannitol ovoalbumin vs ferrous sulphate in iron deficiency anaemia
2005-001510-40Phase 4Active
- Sponsor
- Tedec-Meiji Farma
- Start
- May 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in iron deficiency anemia (IDA) comparing Profer arm with Fero-gradumet arm (2 arms). Primary endpoint: Recovery of haematological parameters. Started May 2006; status: active.
02
Drugs
ferrimannitol ovalbuminIron protein succinylate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2005-001510-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001510-40.